Jove
Visualize
Contact Us

Related Experiment Videos

Neonatal polycythemia: is partial exchange transfusion justified?

Michael S Schimmel1, Ruben Bromiker, Roger F Soll

  • 1Department of Neonatology, Shaare Zedek Medical Center, Jerusalem 91031, Israel. schimmel@szmc.org.il

Clinics in Perinatology
|August 25, 2004
PubMed
Summary

Neonatal polycythemia is often treated to prevent neurologic issues, but current methods like partial exchange transfusion need re-evaluation for effectiveness in preventing long-term harm.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet transfusion thresholds for thrombocytopenic infants.

The Cochrane database of systematic reviews·2026
Same author

Olfactory stimulation for promoting development and preventing morbidity in preterm infants.

The Cochrane database of systematic reviews·2026
Same author

Intrathoracic Kidney Associated with Congenital Diaphragmatic Hernia: Prenatal Detection and Outcomes.

Fetal diagnosis and therapy·2026
Same author

Therapeutic hypothermia for newborns with hypoxic-ischaemic encephalopathy.

The Cochrane database of systematic reviews·2026
Same author

Toward a Harmonized Bronchopulmonary Dysplasia Definition: An International Delphi Process.

Pediatrics·2026
Same author

European Consensus Guidelines on the Management of Respiratory Distress Syndrome (2026).

Neonatology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neonatalogy
  • Pediatric Neurology
  • Hematology

Background:

  • Neonatal polycythemia is clinically significant, often indicating neonatal hyperviscosity.
  • Hyperviscosity is suspected to cause long-term neurologic deficits in children.
  • Current clinical practice relies on newborn hematocrit (Hct) levels for intervention decisions.

Purpose of the Study:

  • To re-evaluate the clinical approach to diagnosing and treating neonatal polycythemia.
  • To question the efficacy of traditional interventions for preventing long-term neurologic consequences.
  • To advocate for a critical review of current therapeutic strategies.

Main Methods:

  • Review of existing clinical practices and literature regarding neonatal polycythemia.
  • Analysis of the diagnostic criteria based on hematocrit (Hct) levels.

Related Experiment Videos

  • Evaluation of the effectiveness of partial exchange transfusion.

    • Main Results:

    • Neonatal polycythemia is a marker for hyperviscosity.
    • Hematocrit (Hct) levels guide therapeutic interventions.
    • The effectiveness of partial exchange transfusion in preventing neurologic damage is uncertain.

    Conclusions:

    • The traditional approach to neonatal polycythemia management requires critical re-assessment.
    • The link between neonatal hyperviscosity and long-term neurologic outcomes needs further investigation.
    • The efficacy of partial exchange transfusion as a preventative measure for neurologic delay is questionable.